|
|
Volumn 131, Issue 6, 2008, Pages 469-477
|
|
Pharmacological, pharmacokinetic, and clinical profile of tadalafil (Cialis®)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLIC GMP;
PHOSPHODIESTERASE I;
PHOSPHODIESTERASE III;
PHOSPHODIESTERASE IV;
PHOSPHODIESTERASE V;
PHOSPHODIESTERASE VII;
TADALAFIL;
AREA UNDER THE CURVE;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG STRUCTURE;
ERECTILE DYSFUNCTION;
HUMAN;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
REVIEW;
SINGLE NUCLEOTIDE POLYMORPHISM;
TIME TO MAXIMUM PLASMA CONCENTRATION;
BLOOD PRESSURE;
CARBOLINES;
CYCLIC GMP;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5;
ERECTILE DYSFUNCTION;
FOOD-DRUG INTERACTIONS;
HUMANS;
MALE;
MUSCLE RELAXATION;
MUSCLE, SMOOTH;
PENIS;
PHOSPHODIESTERASE INHIBITORS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 48849084528
PISSN: 00155691
EISSN: 13478397
Source Type: Journal
DOI: 10.1254/fpj.131.469 Document Type: Review |
|
Times cited : (2)
|
|
References (16)
|
